Magdent

Magdent’s miniaturized electronic device fits into most dental implants to reduce treatment time, improve implant procedures, and increase the number of candidates for implants. 

The Technology & Product

Magdent’s novel technology utilizes electromagnetic fields to stimulate, accelerate, and improve bone formation and quality for shorter, more successful dental implant procedures and suppresses bone infections, making it the only treatment in cases of peri-implantitis and peri-implant mucositis.

Magdent first product, Miniaturized Electromagnetic Device (MED), is small enough to fit most dental implants. MED is easily screwed into the implant and removed at the end of the treatment period using regular protocols.

Magdent’s MED incorporates a battery, microelectronics, and a coil. It fits most implant models in much the same way as today’s simple healing cap. The MED technology actively stimulates, accelerates and improves osseogenesis (bone formation) and osseointegration, resulting in shorter, more successful dental implant placement.

The Magdent device suits candidates who may otherwise not be considered for implants: older people with decreased bone density, diabetics, and patients with bone diseases (osteoporosis, metabolic diseases of the bone), and smokers.

The Company is currently developing solutions for orthopedics based on its unique technology.

The Advantages

Magdent offers key advantages for dentists and patients.

Increases —

  • Amount of bone connection to implant; bone density
  • Success rates
  • Success rates in treatment of peri-implantits
  • # of candidates for implants; patient satisfaction
  • Dentist revenue stream, cash flow, standard of care

Decreases —

  • Treatment time by 2/3
  •  # clinic visits
  • Damage to bone
  • Repeat/repair surgeries

Magdent’s MED has CE approval, and the Company is at initial mass production and sales stage. Magdent started R&D on new versions of its MED, with applications in orthopedics.

The Team

  • Shlomo Barak, D.M.D., CEO, Chairman, and Co-Founder: Internationally known oral and maxillofacial surgeon; published over 45 articles and studies on oral surgery and dentistry
  • Moshe Neuman, D.M.D., Chief Medical Officer and Co-Founder: Experienced periodontist; founded Magdent to address the challenges he faced using current implant devices and technologies; Diplomate, American Board of Periodontology; M.Sc., bone biology
  • Elad Yakobson, COO: Over 15 years of managerial experience, leading large-scale systems to start-up companies and specializing in business development, R&D, and operations; B.Sc., industrial engineering

Status

Stage: Business development (initial sales)
Founded: 2011
Investors: The Trendlines Group, private investor

In the Media

Background & Market

Dental implants are driving a significant of development to meet growing patient demand. Comprised of a screw implanted in the bone, an abutment that fits into the screw, and a crown, the total process is performed in stages, typically with a break of three to six months between the stages to allow the bone to heal and grow around the implant (osseointegration). In addition, the rate of implant failure is significantly higher in patients with poor bone quality (~20%) or insufficient bone (~30%). Reduced bone quality is typically more acute in older patients, the population with the greatest need for implants, and is seen very often in cases of diabetes, osteoporosis, heavy smokers, and others.

The global dental implant market is $4.2 billion that consists of 10 million implants per year. The market has a growth rate of 6% a year. The orthopedics field Magdent is entering is estimated at $41 billion annually.

Media


Watch COO Elad Yakobson's interview on Israel Daily TV.


See the Magdent animation.

Magdent device

Magdent's Miniaturized Electromagnetic Device (MED).

Contact

Shlomo Barak, D.M.D., CEO
+972.52.830.0033
barak@magdentmed.com

Elad Yakobson, COO
+972.54.280.1876
elad@magdentmed.com

www.magdentmed.com

Magdent logo card